EurekAlert! -
6 Oct 2014 06:00
(Wiley) A new phase 1 safety trial has demonstrated that idarubicin-loaded beads are well tolerated by patients but are toxic to liver cancer cells. Idarubicin is an anthracycline that is currently used to treat leukemias.
Share this Article